Liothyronine (T3) for Bipolar Depression

Completed · Phase 3 · Has a placebo group

Conditions studied: Depression, Bipolar Disorder

In brief

This study evaluates the efficacy of the thyroid hormone T3 for depression in patients with bipolar disorder. In this study patients will be randomized to receive T3 or placebo.

Key facts

Study ID
NCT00790738
Run by
Northwell Health
People needed
11
Starts
2008-07-01
Expected to finish
2012-07-01
Last updated by the study team
2015-07-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.